| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/06/2000 | WO2000039131A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039118A1 Aromatic amides |
| 07/06/2000 | WO2000039117A1 HETEROROAROMATIC AMIDES AS INHIBITOR OF FACTOR Xa |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039111A1 Antithrombotic amides |
| 07/06/2000 | WO2000039108A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | WO2000039105A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders |
| 07/06/2000 | WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000039092A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa |
| 07/06/2000 | WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000038659A1 Transdermal drug delivery system |
| 07/06/2000 | WO2000038657A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000038535A1 Food-induced antisecretory proteins in egg yolk |
| 07/06/2000 | WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000013703A3 Methods of treating hypertension and compositions for use therein |
| 07/06/2000 | WO1999061600A9 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | WO1999041282A8 Therapeutic uses of keratinocyte growth factor-2 |
| 07/06/2000 | DE19928528A1 Well tolerated herbal antiarteriosclerotic medicament for combating arterial blood flow deficiency sequelae, comprising capsule containing Ginkgo biloba, Ammi visnaga and Allium sativum components |
| 07/06/2000 | CA2361149A1 Aromatic amides |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358095A1 Heteroroaromatic amides as inhibitor of factor xa |
| 07/06/2000 | CA2358094A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | CA2358091A1 Antithrombotic amides |
| 07/06/2000 | CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds |
| 07/06/2000 | CA2356834A1 Methods for reducing adverse side effects associated with cellular transplantation |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356424A1 Serine protease inhibitor |
| 07/06/2000 | CA2356214A1 Heterocyclic amides as inhibitors of factor xa |
| 07/06/2000 | CA2355872A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2355281A1 Thrombin inhibitors |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2318356A1 Pharmaceutical formulation containing a hyaluronic acid-splitting enzyme of microbial origin |
| 07/05/2000 | EP1016414A2 Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans |
| 07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015490A1 No-modified hemoglobins and uses therefor |
| 07/05/2000 | EP1015458A1 Furopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015456A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors |
| 07/05/2000 | EP1015454A1 Method of inhibiting serine protease enzymes |
| 07/05/2000 | EP1015449A1 (hetero)aryl-sulfonamide derivatives, their preparation and their use as factor xa inhibitors |
| 07/05/2000 | EP1015443A1 Thromboxane ligands |
| 07/05/2000 | EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 07/05/2000 | EP1015089A1 Blood processing systems and methods which optically derive the volume of platelets contained in a plasma constituent |
| 07/05/2000 | EP1015030A2 Photochemotherapeutic compositions |
| 07/05/2000 | EP1015022A1 New improved formulation for treatment of thromboembolism |
| 07/05/2000 | EP1015020A1 Pharmaceutical substance containing various vitamin k-dependent factors |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014962A1 Antithrombotic agents |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP0871664A4 Novel chemokine for mobilizing stem cells |
| 07/05/2000 | EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications |
| 07/05/2000 | CN1259143A Oligosaccharide mixtures having antithrombotic activity |
| 07/04/2000 | US6084074 Stabilized aqueous liquid preparations of blood coagulation factor XIII |
| 07/04/2000 | US6084060 Amino acid sequence of protein that inhibits differentiation of progenitor cells; for expanding progenitor cell populations ex vivo to increase chances of engraftation and gene therapy |
| 07/04/2000 | US6083982 Stimulating sodium excretion in the urine of a mammal comprising administering to the mammal a alkoxyalkyl or hydroxy alkyl substituted phenolic compound |
| 07/04/2000 | US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors |
| 07/04/2000 | US6083971 Certain oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083935 Consisting essentially of an effective amount of n-acetylglucosamine and electrolytes |
| 07/04/2000 | US6083914 Antithrombotic peptides |
| 07/04/2000 | US6083913 Peptides and compounds that bind to a thrombopoietin receptor |
| 07/04/2000 | US6083909 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 07/04/2000 | US6083905 Method and means for detecting and treating disorders in the blood coagulation cascade |
| 07/04/2000 | US6083501 Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 07/04/2000 | US6083497 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| 07/04/2000 | CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/29/2000 | WO2000037051A1 Aerosol formulations for buccal and pulmonary application |
| 06/29/2000 | WO2000012683A3 Stem cells bearing an fgf receptor on the cell surface |
| 06/29/2000 | WO2000012497A3 Quinazoline derivatives as medicaments |
| 06/29/2000 | CA2356174A1 Kidney disease detection and treatment |
| 06/29/2000 | CA2356162A1 Substituted tricyclics |
| 06/29/2000 | CA2356159A1 Novel spla2 inhibitors |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
| 06/29/2000 | CA2355704A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/29/2000 | CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit |